Amphion Innovations PLC

Receive alerts
Market Cap:
0.15 GBX
52 weeks high
52 weeks low

In brief

Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.

Amphion has a significant shareholding in 7 Partner Companies developing proven technologi es targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

Amphion also has a specialized entity, DataTern, Inc., established to exploit IP opportunities within the Company's Partner Companies.


Deep dive We explore the investor case for growth companies


  • Investment firm focused on medical and technology sectors
  • Concentrated portfolio of seven companies
  • Motif Bio and Polarean Imaging are its listed holdings